Bristol-Myers Squibb | BMY - Marktkapitalisierung

Aktienkurs
58.90
Täglich Wechseln
-0.30 -0.51%
Monatlich
-2.05%
Jährlich
16.73%
Q2 Prognose
57.81




Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Abbott USD 217.86B 15.25B 2025-12
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
J&J USD 500.24B 67.44B 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.97B 105M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Zoetis USD 55.45B 9.4B 2025-12